Marshall Wace
ABEO icon

Marshall Wace’s Abeona Therapeutics ABEO Stock Holding History

Marshall Wace’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
194,827
-21,478
-10% -$118K ﹤0.01% 2102
2026
Q1 		$969K Buy
+216,305
New +$1.08M ﹤0.01% 2148
2025
Q4 		– Sell
-11,800
Closed -$62.3K – 2901
2025
Q3 		$62.3K Sell
11,800
-73,324
-86% -$465K ﹤0.01% 2711
2025
Q2 		$484K Sell
85,124
-247,276
-74% -$1.41M ﹤0.01% 2160
2025
Q1 		$1.58M Buy
332,400
+281,072
+548% +$1.53M ﹤0.01% 1571
2024
Q4 		$286K Sell
51,328
-32,846
-39% -$202K ﹤0.01% 2246
2024
Q3 		$532K Buy
+84,174
New +$439K ﹤0.01% 1903
2024
Q2 		– Sell
-128,903
Closed -$935K – 2485
2024
Q1 		$935K Buy
128,903
+81,047
+169% +$514K ﹤0.01% 1685
2023
Q4 		$240K Buy
+47,856
New +$211K ﹤0.01% 1932
2019
Q3 		– Sell
-530
Closed -$63K – 1640
2019
Q2 		$63K Buy
530
+167
+46% +$28K ﹤0.01% 1285
2019
Q1 		$67K Sell
363
-4,155
-92% -$743K ﹤0.01% 1495
2018
Q4 		$806K Sell
4,518
-7,428
-62% -$1.62M 0.01% 970
2018
Q3 		$3.82M Buy
+11,946
New +$4.24M 0.03% 524

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace's ABEO Position: Q2 2026 in Review

Marshall Wace reduced its Abeona Therapeutics (ABEO) stake by 9.9% in Q2 2026, selling an estimated $118K and leaving 194,827 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Marshall Wace first reported a position in ABEO in Q3 2018 and has held it in 13 quarters since. The position peaked at $3.82M in Q3 2018. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Marshall Wace held 194,827 shares of Abeona Therapeutics worth $1.2M as of Q2 2026.
  • Marshall Wace sold 21,478 Abeona Therapeutics shares in Q2 2026, an estimated $118K.
  • Abeona Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2102 holding.
  • Marshall Wace first reported a position in Abeona Therapeutics in Q3 2018 and has held it in 13 quarters since.
  • Marshall Wace's Abeona Therapeutics position peaked at $3.82M in Q3 2018.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.